NCT00625014已完成不适用
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans
Leiden University Medical Center1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2005年3月最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 8
- 试验地点
- 1
- 主要终点
- To determine the effect of subchronic haloperidol treatment on HGO, whole body peripheral glucose disposal, fatty acid flux and fuel oxidation.
研究概览
简要总结
We hypothesized that short-term treatment with haloperidol induces insulin resistance through a mechanistic route that is independent of weight gain. We therefore treated healthy non-obese men with haloperidol for 8 days, and studied the impact of these intervention on glucose and lipid metabolism by hyperinsulinemic euglycemic clamp, isotope dilution technology and indirect calorimetry.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 40 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy men
- •20 kg/m2 < BMI < 26 kg/m2
- •Age 20-40 years
- •FPG < 6 mmol/L
排除标准
- •FPG > 6 mmol/L
- •BMI > 26 kg/m2
- •Psychiatric disorders and/or use of antipsychotic or antidepressants drugs at present or in the past.
- •A positive family history of schizophrenia
- •Any significant chronic disease
- •Renal, hepatic or endocrine disease
- •Use of medication known to influence lipolysis and/or glucose metabolism
- •Total cholesterol > 7mmol/L and/or triglycerides > 2 mmol/L
- •Recent weight changes or attempts to loose weight (> 3 kg weight gain or loss, within the last 3 months)
- •Difficulties to insert an intravenous catheter
- •Smoking (current)
- •Severe claustrophobia (ventilated hood)
- •Recent blood donation (within the last 2 months)
- •Recent participation in other research projects (within the last 3 months), participation in 2 or more projects in one year
- •Extensive sporting activities (more than 10 hours of exercise per week)
研究组 & 干预措施
1
Experimental
Healthy men
干预措施: Haloperidol (Drug)
结局指标
主要结局
To determine the effect of subchronic haloperidol treatment on HGO, whole body peripheral glucose disposal, fatty acid flux and fuel oxidation.
时间窗: 8 days
次要结局
未报告次要终点
研究者
Hanno Pijl
Prof dr H Pijl
Leiden University Medical Center
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy HumansInsulin ResistanceDyslipidemiaNCT00625170Leiden University Medical Center11
尚未招募
不适用
Hepatic insulin resistance and Dopaminergic dysfunction in a Ultra High Risk (UHR) population for Schizophreniadelusionpsychosis1001842410039628NL-OMON31345Academisch Medisch Centrum40
已完成
不适用
Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell RecoveryType 1 DiabetesHypoglycemiaNCT01272583Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)16
已完成
不适用
Systemic Effects of Epidural Methylprednisolone Injection on Glucose Tolerance in Diabetic PatientsHealthyDiabetesNCT01420497Centre Hospitalier Universitaire Vaudois25
已完成
不适用
Raclopride-PET/MRTDiabetes Mellitus, Type 2NCT03637075University Hospital Tuebingen24